🇺🇸 oral hypoglycemic agents in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Fluctuation — 2 reports (14.29%)
  2. Drug Interaction — 2 reports (14.29%)
  3. Hepatitis — 2 reports (14.29%)
  4. Rhabdomyolysis — 2 reports (14.29%)
  5. Anaemia — 1 report (7.14%)
  6. Angioedema — 1 report (7.14%)
  7. Blood Creatine Increased — 1 report (7.14%)
  8. Blood Potassium Increased — 1 report (7.14%)
  9. Blood Pressure Diastolic Decreased — 1 report (7.14%)
  10. Cataplexy — 1 report (7.14%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is oral hypoglycemic agents approved in United States?

oral hypoglycemic agents does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for oral hypoglycemic agents in United States?

Queen Elizabeth II Health Sciences Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.